These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134 [TBL] [Abstract][Full Text] [Related]
3. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314 [TBL] [Abstract][Full Text] [Related]
4. Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation. Cesar Machado MC; Filho RK; El Bacha IAH; de Oliveira IS; Ribeiro CMF; de Souza HP; Parise ER Am J Case Rep; 2022 Aug; 23():e936250. PubMed ID: 35978523 [TBL] [Abstract][Full Text] [Related]
5. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929 [TBL] [Abstract][Full Text] [Related]
6. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. Edwards K; Allison M; Ghuman S BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168538 [TBL] [Abstract][Full Text] [Related]
7. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Gudnason HO; Björnsson HK; Gardarsdottir M; Thorisson HM; Olafsson S; Bergmann OM; Björnsson ES Dig Liver Dis; 2015 Jun; 47(6):502-7. PubMed ID: 25840876 [TBL] [Abstract][Full Text] [Related]
8. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients]. Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System. Nakanishi Y; Saxena R Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426 [TBL] [Abstract][Full Text] [Related]
13. Marked eosinophilia as the first manifestation of sclerosing cholangitis. Horiuchi K; Kakizaki S; Kosone T; Ichikawa T; Sato K; Takagi H; Mori M; Sakurai S; Fukusato T Intern Med; 2009; 48(16):1377-82. PubMed ID: 19687582 [TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients. Ferreira FB; Mourato M; Bragança S; Paulo JB; Sismeiro R; Pereira A; Mónica AN; Lourenço LC; Cardoso M Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102048. PubMed ID: 36347499 [TBL] [Abstract][Full Text] [Related]